The results show that baicalein can inhibit angiogenesis [58] and prevent tumor metastasis [59], and it can control the abnormal proliferation and cell cycle of cancer cells by inhibiting Ezrin and activating p53 pathway-related proteins [60]. Here, EZR is linked to neoplasm.